This report expands on the information provided in the original Roadmap to equip stakeholders with current clinical, cost, and patent information to inform decision-making about the best strategies to expand currently limited access to DTG.
The Roadmap Special Edition Report on Dolutegravir
Join us to stay updated
and help make lifesaving medicines accessible to all